RETRACTED–Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study
The British Journal of Psychiatry · 2025
DOI: 10.1192/bjp.2024.250 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The British Journal of Psychiatry, 2025. Verfasst von Natalie T Mills und 21 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Psychiatry, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Anti-Anxiety Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Anxiety disorders and treatment-resistant major depressive disorder (TRD) are often comorbid. Studies suggest ketamine has anxiolytic and antidepressant properties.
Aims
To investigate if subcutaneous racemic ketamine, delivered twice weekly for 4 weeks, reduces anxiety in people with TRD.
Method
The Ketamine for Adult Depression Study was a multisite 4-week randomised, double-blind, active (midazolam)-controlled trial. The study initially used fixed low dose ketamine (0.5 mg/kg, cohort 1), before protocol revision to flexible, response-guided dosing (0.5–0.9 mg/kg, cohort 2). This secondary analysis assessed anxiety using the Hamilton Anxiety (HAM-A) scale (primary measure) and ‘inner tension’ item 3 of the Montgomery–Åsberg Depression Rating Scale (MADRS), at baseline, 4 weeks (end treatment) and 4 weeks after treatment end. Analyses of change in anxiety between ketamine and midazolam groups included all participants who received at least one treatment ( n = 174), with a mixed effects repeated measures model used to assess the primary anxiety measure. The trial was registered at www.anzctr.org.au (ACTRN12616001096448).
Results
In cohort 1 ( n = 68) the reduction in HAM-A score was not statistically significant: −1.4 (95% CI [−8.6, 3.2], P = 0.37), whereas a significant reduction was seen for cohort 2 ( n = 106) of −4.0 (95% CI [−10.6, −1.9], P = 0.0058), favouring ketamine over midazolam. These effects were mediated by total MADRS and were not maintained at 4 weeks after treatment end. MADRS item 3 was also significantly reduced in cohort 2 ( P = 0.026) but not cohort 1 ( P = 0.96).
Conclusion
Ketamine reduces anxiety in people with TRD when administered subcutaneously in adequate doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Psychiatry, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
- Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, Australia.
- Black Dog Institute, Randwick, Australia.
- Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Australian Research Council Centre of Excellence for Children and Families over the Life Course, University of Sydney, Sydney, Australia.
- Australian Centre for Heart Health, Royal Melbourne Hospital, North Melbourne, Australia.
ORCID-Profile: Natalie T Mills, Stevan Nikolin, Nick Glozier, Bernhard T Baune, Philip B Mitchell, Michael Berk, Mary Lou Chatterton, Sean Hood, Colleen K Loo
Zitieren
APA
Mills, N. T., Nikolin, S., Glozier, N., Barton, D., Baune, B. T., Fitzgerald, P. B., Glue, P., Sarma, S., Rodgers, A., Hadzi-Pavlovic, D., Alonzo, A., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M. L., Somogyi, A. A., Mihalopoulos, C., …, & Loo, C. K. (2025). RETRACTED–Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2024.250
Vancouver
Mills NT, Nikolin S, Glozier N, Barton D, Baune BT, Fitzgerald PB, et al. RETRACTED–Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study. The British Journal of Psychiatry. 2025. doi:10.1192/bjp.2024.250
BibTeX
@article{Mills2025,
author = {Mills, Natalie T and Nikolin, Stevan and Glozier, Nick and Barton, David and Baune, Bernhard T and Fitzgerald, Paul B and Glue, Paul and Sarma, Shanthi and Rodgers, Anthony and Hadzi-Pavlovic, Dusan and Alonzo, Angelo and Dong, Vanessa and Martin, Donel and Mitchell, Philip B and Berk, Michael and Carter, Gregory and Hackett, Maree L and Somogyi, Andrew A and Mihalopoulos, Cathrine and Chatterton, Mary Lou and Hood, Sean and Loo, Colleen K},
title = {RETRACTED–Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study},
journal = {The British Journal of Psychiatry},
year = {2025},
doi = {10.1192/bjp.2024.250}
}
EUVIMED